Cipla signs pact with Novartis Pharma AG for diabetes drug Galvus

The perpetual license agreement is to manufacture and market the drug and its combination brands from January 2026

from Latest News , Latest News Live and Breaking News Today | The Hindu https://ift.tt/QvTwrnA
https://ift.tt/PkipyA6